More
    HomeMarketingPatients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of...

    Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats



    U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.



    Source link

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Must Read

    spot_img